Form 4: Surrozen Director Acquires Options in Latest Transaction
SEC Form 4 Filing
Mary Haak-Frendscho, a director of Surrozen, Inc., reported the acquisition of options to purchase 1,333 shares of common stock.
Summary
- On May 14, 2025, Mary Haak-Frendscho, a director of Surrozen, Inc., acquired options to purchase 1,333 shares of the company's common stock at an exercise price of $6.50.
- The options vest and become exercisable on May 14, 2026, subject to continuous service as a director, and expire on May 14, 2035.
- Following the transaction, Ms. Haak-Frendscho directly owns 1,333 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an insider transaction, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding director compensation and alignment with company interests.
Key Dates
| Date | Description |
|---|---|
| 05/14/2025 | Date of earliest transaction: acquisition of options. |
| 05/14/2025 | Grant date of the options. |
| 05/14/2026 | Options vest and become exercisable. |
| 05/14/2035 | Expiration date of the options. |
| 05/15/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Surrozen, Director, Options, SRZN, Acquisition, Haak-Frendscho, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.